Irwin A. Quintela
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Irwin A. Quintela has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Meng-Wei Lin
Department of Biological Science and Technology National Yang Ming Chiao Tung University Hsinchu Taiwan
3 shared publications - Vivian C. H. Wu
Produce Safety and Microbiology Research Unit, Department of Agriculture, Agricultural Research Service, Western Regional Research Center, Albany, USA
3 shared publications - Chih-Sheng Lin
Department of Biological Science and Technology National Yang Ming Chiao Tung University Hsinchu Taiwan
2 shared publications - Cheng-Han Lin
Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu 30068, Taiwan
1 shared publication Chih-Sheng Lin
Department of Biological Science and Technology, National Yang Ming Chiao Tung University
1 shared publication- Hua-Hsin Chiang
Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu 30068, Taiwan
1 shared publication
Latest Publications
- Open Access
- 25 November 2025
- Published by American Society for Microbiology in Journal of Virology
- Vol. 99 (11) , e0148425
Recent advances in lateral flow devices and point-of-care diagnostics for highly pathogenic avian influenza A viruses
There has been a resurgence and ongoing outbreak of avian influenza since early 2024. Avian influenza, caused by influenza A viruses, poses significant threats to both avian populations and public health due to its zoonotic potential. Highly pathogenic avian influenza (HPAI) virus, such as the H5N1 and H7 subtypes, has a high mortality rate. Traditional detection methods, i.e., virus isolation and reverse transcription quantitative PCR (qRT-PCR), are reliable for diagnosis but time-consuming and labor-intensive. Rapid and accurate detection of avian influenza A viruses is crucial to prevent widespread outbreaks and minimize economic losses. Field-ready and point-of-care (POC) diagnostics, such as lateral flow assays (LFAs) offer a rapid, early, and large-scale approach for detecting avian influenza A virus infections. Early detection in HPAI management is a key factor in improving treatment effectiveness and reducing the negative impact on animal health. This minireview introduces the principles and techniques of current field-ready and POC diagnostics, emphasizing LFAs for HPAI detection. It also outlines and compares their development, applications, and availability in the market. Notably, advanced techniques such as LFAs-integrated clustered regularly interspaced short palindromic repeats (CRISPR) have expanded HPAI diagnostic capabilities and have also been reviewed. CRISPR-based LFAs use guide RNA to detect viral sequences, activating Cas enzymes that generate a visible signal on test strips, enabling a rapid and sensitive detection method. To our knowledge, this is the first comprehensive review summarizing LFA-based HPAI diagnostics in the context of the 2024 resurgence, offering timely insight into their potential roles in outbreak preparedness and response.
- 25 November 2025
- Published by American Society for Microbiology in Journal of Virology
- Vol. 99 (11) , e0148425
Open AccessRecent advances in lateral flow devices and point-of-care diagnostics for highly pathogenic avian influenza A viruses
There has been a resurgence and ongoing outbreak of avian influenza since early 2024. Avian influenza, caused by influenza A viruses, poses significant threats to both avian populations and public health due to its zoonotic potential. Highly pathogenic avian influenza (HPAI) virus, such as the H5N1 and H7 subtypes, has a high mortality rate. Traditional detection methods, i.e., virus isolation and reverse transcription quantitative PCR (qRT-PCR), are reliable for diagnosis but time-consuming and labor-intensive. Rapid and accurate detection of avian influenza A viruses is crucial to prevent widespread outbreaks and minimize economic losses. Field-ready and point-of-care (POC) diagnostics, such as lateral flow assays (LFAs) offer a rapid, early, and large-scale approach for detecting avian influenza A virus infections. Early detection in HPAI management is a key factor in improving treatment effectiveness and reducing the negative impact on animal health. This minireview introduces the principles and techniques of current field-ready and POC diagnostics, emphasizing LFAs for HPAI detection. It also outlines and compares their development, applications, and availability in the market. Notably, advanced techniques such as LFAs-integrated clustered regularly interspaced short palindromic repeats (CRISPR) have expanded HPAI diagnostic capabilities and have also been reviewed. CRISPR-based LFAs use guide RNA to detect viral sequences, activating Cas enzymes that generate a visible signal on test strips, enabling a rapid and sensitive detection method. To our knowledge, this is the first comprehensive review summarizing LFA-based HPAI diagnostics in the context of the 2024 resurgence, offering timely insight into their potential roles in outbreak preparedness and response.
- 30 April 2025
- Published by Wiley in Journal of Food Safety
- Vol. 45 (3) , e70017
Review of Recent Advances in Aptasensor for the Detection of Pathogenic Escherichia coli O157 : H7
Escherichia coli ( E. coli ) O157: H7 is a critical pathogen due to its association with severe conditions like hemorrhagic colitis and hemolytic uremic syndrome. The prevalence of this pathogen underscores the urgent need for effective food and environmental safety measures. Among emerging innovations, aptamer‐based biosensors (aptasensors) offer increased sensitivity and reduced detection times compared to traditional methods for identifying E. coli O157: H7. Aptamers, short single‐stranded DNA (ssDNA) or RNA molecules, act as bio‐recognition elements, exhibiting high specificity and affinity for foodborne pathogens. This scoping review examines recent advancements in aptasensor technology over the past 5 years, focusing on platforms targeting E. coli O157: H7 detection. Key elements such as detection targets, sample types, transducers, sensing mechanisms, fabrication methods, and detection limits were analyzed to identify the strengths and limitations of current aptasensor platforms. The findings indicate that most optical aptasensors, particularly fluorescence‐based ones, have been developed for detecting E. coli O157: H7 in water, food, and milk samples. Currently developing aptasensors show promise, offering reliable alternatives with improved detection capabilities. Nonetheless, further studies are still needed to validate their sensitivity and specificity to facilitate broader applications. This review explores the latest developments across diverse aptasensor types, including electrochemical, optical, and magnetic approaches, and examines their working principles, advantages, and limitations. It highlights the potential of aptasensors for practical applications in agricultural and environmental samples, emphasizing their role in advancing safety monitoring systems.
- 30 April 2025
- Published by Wiley in Journal of Food Safety
- Vol. 45 (3) , e70017
Review of Recent Advances in Aptasensor for the Detection of Pathogenic Escherichia coli O157 : H7
Escherichia coli ( E. coli ) O157: H7 is a critical pathogen due to its association with severe conditions like hemorrhagic colitis and hemolytic uremic syndrome. The prevalence of this pathogen underscores the urgent need for effective food and environmental safety measures. Among emerging innovations, aptamer‐based biosensors (aptasensors) offer increased sensitivity and reduced detection times compared to traditional methods for identifying E. coli O157: H7. Aptamers, short single‐stranded DNA (ssDNA) or RNA molecules, act as bio‐recognition elements, exhibiting high specificity and affinity for foodborne pathogens. This scoping review examines recent advancements in aptasensor technology over the past 5 years, focusing on platforms targeting E. coli O157: H7 detection. Key elements such as detection targets, sample types, transducers, sensing mechanisms, fabrication methods, and detection limits were analyzed to identify the strengths and limitations of current aptasensor platforms. The findings indicate that most optical aptasensors, particularly fluorescence‐based ones, have been developed for detecting E. coli O157: H7 in water, food, and milk samples. Currently developing aptasensors show promise, offering reliable alternatives with improved detection capabilities. Nonetheless, further studies are still needed to validate their sensitivity and specificity to facilitate broader applications. This review explores the latest developments across diverse aptasensor types, including electrochemical, optical, and magnetic approaches, and examines their working principles, advantages, and limitations. It highlights the potential of aptasensors for practical applications in agricultural and environmental samples, emphasizing their role in advancing safety monitoring systems.
- Open Access
Using Nano-Luciferase Binary (NanoBiT) Technology to Assess the Interaction Between Viral Spike Protein and Angiotensin-Converting Enzyme II by Aptamers
Nano-luciferase binary technology (NanoBiT)-based pseudoviral sensors are innovative tools for monitoring viral infection dynamics. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells via its trimeric surface spike protein, which binds to the human angiotensin-converting enzyme II (hACE2) receptor. This interaction is crucial for viral entry and serves as a key target for therapeutic interventions against coronavirus disease 2019 (COVID-19). Aptamers, short single-stranded DNA (ssDNA) or RNA molecules, are highly specific, high-affinity biorecognition elements for detecting infective pathogens. Despite their potential, optimizing viral infection assays using traditional protein–protein interaction (PPI) methods often face challenges in optimizing viral infection assays. In this study, we selected and evaluated aptamers for their ability to interact with viral proteins, enabling the dynamic visualization of infection progression. The NanoBiT-based pseudoviral sensor demonstrated a rapid increase in luminescence within 3 h, offering a real-time measure of viral infection. A comparison of detection technologies, including green fluorescent protein (GFP), luciferase, and NanoBiT technologies for detecting PPI between the pseudoviral spike protein and hACE2, highlighted NanoBiT’s superior sensitivity and performance, particularly in aptamer selection. This bioluminescent system provides a robust, sensitive, and early-stage quantitative approach to studying viral infection dynamics.
Open AccessUsing Nano-Luciferase Binary (NanoBiT) Technology to Assess the Interaction Between Viral Spike Protein and Angiotensin-Converting Enzyme II by Aptamers
Nano-luciferase binary technology (NanoBiT)-based pseudoviral sensors are innovative tools for monitoring viral infection dynamics. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells via its trimeric surface spike protein, which binds to the human angiotensin-converting enzyme II (hACE2) receptor. This interaction is crucial for viral entry and serves as a key target for therapeutic interventions against coronavirus disease 2019 (COVID-19). Aptamers, short single-stranded DNA (ssDNA) or RNA molecules, are highly specific, high-affinity biorecognition elements for detecting infective pathogens. Despite their potential, optimizing viral infection assays using traditional protein–protein interaction (PPI) methods often face challenges in optimizing viral infection assays. In this study, we selected and evaluated aptamers for their ability to interact with viral proteins, enabling the dynamic visualization of infection progression. The NanoBiT-based pseudoviral sensor demonstrated a rapid increase in luminescence within 3 h, offering a real-time measure of viral infection. A comparison of detection technologies, including green fluorescent protein (GFP), luciferase, and NanoBiT technologies for detecting PPI between the pseudoviral spike protein and hACE2, highlighted NanoBiT’s superior sensitivity and performance, particularly in aptamer selection. This bioluminescent system provides a robust, sensitive, and early-stage quantitative approach to studying viral infection dynamics.